These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic. Shao C; Shi Y; Chen R; Liu X; Huang H; Zhao Y; Xu K; Chen K; Wang M; Xu Z J Med Virol; 2023 Sep; 95(9):e29098. PubMed ID: 37707416 [TBL] [Abstract][Full Text] [Related]
8. [When COVID-19 encounters interstitial lung disease: challenges and management]. Ren YH; Wang SY; Liu M; Guo YM; Dai HP Zhonghua Jie He He Hu Xi Za Zhi; 2020 Aug; 43(8):633-638. PubMed ID: 32198915 [TBL] [Abstract][Full Text] [Related]
9. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia]. ; Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):827-833. PubMed ID: 32992435 [TBL] [Abstract][Full Text] [Related]
10. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K Front Immunol; 2020; 11():587517. PubMed ID: 33123171 [TBL] [Abstract][Full Text] [Related]
16. Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic. Guiot J; Henket M; Frix AN; Delvaux M; Denis A; Giltay L; Thys M; Gester F; Moutschen M; Corhay JL; Louis R; Respir Investig; 2020 Nov; 58(6):437-439. PubMed ID: 32978099 [TBL] [Abstract][Full Text] [Related]
17. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease. Sarkar P; Avram C; Chaudhuri N Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 and acute exacerbation of interstitial lung disease. Kondoh Y; Kataoka K; Ando M; Awaya Y; Ichikado K; Kataoka M; Komase Y; Mineshita M; Ohno Y; Okamoto H; Ooki T; Tasaka Y; Tomioka H; Suda T Respir Investig; 2021 Sep; 59(5):675-678. PubMed ID: 34272158 [TBL] [Abstract][Full Text] [Related]